Tunstall to market Honeywell HomMed patient monitors in UK
9 October 2005
Brookfiled Wis, USA. Tunstall, a UK-based leader in telecare and
telehealth solutions, has announced a distribution and alliance agreement
with Honeywell HomMed(R), a leading provider of remote patient monitoring
devices in the United States.
"We are delighted to be able to offer Honeywell HomMed as part of our
telecare and telemedicine portfolio," said James Buckley, Tunstall's Chief
Executive Officer. "This alliance will help us to deliver more proactive
models of care for the management of chronic diseases as part of the
Government's national service framework."
Tunstall will be offering Honeywell's HomMed Genesis monitor throughout
the United Kingdom, allowing health care professionals to monitor their
patients' vital signs daily. As a result, if patients with chronic
conditions, such as diabetes, congestive heart failure and lung disorders,
suffer a change in health status, proactive medical intervention can take
place. To date, more than 350,000 patients have benefited from Honeywell
HomMed remote patient monitors.
There are already 300 clinical sites using HomMed Genesis. "This alliance
will now give us valuable means of introducing the Honeywell HomMed remote
monitoring solution into the European market," said Herschel Peddicord,
Honeywell HomMed's president and Chief Executive Officer.